Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Robert A Ory, MD
Internal Medicine · FEDERAL WAY, WA · NPI 1891704136
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 897 | 264 |
| Lisinopril | Lisinopril | 502 | 140 |
| Losartan Potassium | Losartan Potassium | 415 | 127 |
| Amlodipine Besylate | Amlodipine Besylate | 404 | 125 |
| Levothyroxine Sodium | Levothyroxine Sodium | 333 | 92 |
| Metformin Hcl | Metformin Hcl | 330 | 95 |
| Omeprazole | Omeprazole | 291 | 74 |
| Gabapentin | Gabapentin | 211 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 209 | 60 |
| Metoprolol Succinate | Metoprolol Succinate | 201 | 58 |
| Tamsulosin Hcl | Tamsulosin Hcl | 200 | 52 |
| Simvastatin | Simvastatin | 182 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 152 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 141 | 41 |
| Glimepiride | Glimepiride | 139 | 36 |
| Potassium Chloride | Potassium Chloride | 118 | 39 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 113 | 36 |
| Lovastatin | Lovastatin | 107 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 106 | 44 |
| Citalopram Hbr | Citalopram Hydrobromide | 104 | 25 |
| Tramadol Hcl | Tramadol Hcl | 101 | 27 |
| Alendronate Sodium | Alendronate Sodium | 98 | 28 |
| Sertraline Hcl | Sertraline Hcl | 93 | 26 |
| Xarelto | Rivaroxaban | 93 | 18 |
| Meloxicam | Meloxicam | 91 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 21 |
| Allopurinol | Allopurinol | 87 | 28 |
| Trazodone Hcl | Trazodone Hcl | 84 | 26 |
| Eliquis | Apixaban | 81 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 79 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 76 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 74 | 23 |
| Metformin Hcl Er | Metformin Hcl | 73 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 15 |
| Furosemide | Furosemide | 71 | 18 |
| Lorazepam | Lorazepam | 68 | 16 |
| Atenolol | Atenolol | 66 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 14 |
| Ozempic | Semaglutide | 62 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 62 | 14 |
| Carvedilol | Carvedilol | 60 | 15 |
| Jardiance | Empagliflozin | 59 | 21 |
| Donepezil Hcl | Donepezil Hcl | 56 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 56 | 15 |
| Spironolactone | Spironolactone | 56 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 55 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 52 | 12 |
| Mirtazapine | Mirtazapine | 47 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 46 | 13 |
| Finasteride | Finasteride | 44 | 13 |
| Montelukast Sodium | Montelukast Sodium | 44 | 11 |
| Pregabalin | Pregabalin | 43 | suppressed |
| Alprazolam | Alprazolam | 41 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 39 | suppressed |
| Ezetimibe | Ezetimibe | 38 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 38 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | 12 |
| Famotidine | Famotidine | 36 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | 12 |
| Clonazepam | Clonazepam | 33 | suppressed |
| Memantine Hcl | Memantine Hcl | 33 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 33 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 25 |
| Glipizide Er | Glipizide | 30 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Risperidone | Risperidone | 27 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | 12 |
| Celecoxib | Celecoxib | 24 | suppressed |
| Estradiol | Estradiol | 24 | 11 |
| Nystatin | Nystatin | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 24 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 23 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Prednisone | Prednisone | 23 | 16 |
| Ipratropium Bromide | Ipratropium Bromide | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Lidocaine | Lidocaine | 21 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Dutasteride | Dutasteride | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Carbamazepine Er | Carbamazepine | 17 | suppressed |
| Diazepam | Diazepam | 17 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 13 |
| Azithromycin | Azithromycin | 15 | 15 |
| Cephalexin | Cephalexin | 15 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Baclofen | Baclofen | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error